evf_t
EVF Home Page EVF Aims EVF Meetings EVF Membership EVF News EVF Useful Links EVF Contact
 
13th Annual Meeting





 
Google

WWW EVF site
 
Visitor:



Provisional Scientific Programme

Final Program and book of abstracts

THURSDAY 28 June 2012

09.30-12.00    Joint Meeting with the Italian College of Phlebology (CIF)
                        Presidents: Vincenzo Gasbarro
                        Chair: Atillo Cavezzi, Peter Neglen
                       
                        Debate: Post-thrombotic syndrome needs surgical correction
09.30-9.42       For the motion: Oscar Maleti (Italy)
09.42-9.54       Against the motion: Jean-Jerome Guex (France)
9.54-10.20       Discussion

                        Debate: Perforators veins need to be always treated
10.20-10.32     For the motion: Mark Whiteley (UK)
10.32-10.44     Against the motion: Massimo Cappelli
10.44-11.10     Discussion

                        Debate: Can Duplex scanner allow a tailored treatment of the incompetent great saphenous vein?
11.10-11.22     For the motion: Paolo Zamboni (Italy)
11.22-11.34     Against the motion: Philip Coleridge-Smith (UK)
11.34-12.00     Discussion

12.00-13.00     Lunch

13.00-15.00     Didactic Session 1: "Surgery, endovascular procedures, foam sclerotherapy for varicose veins: evidence
                        or economy based?"
                        Chair: Stefano Ricci, Philip Coleridge-Smith

13.00

Why I perform - Surgery: Marianne de Maeseneer (Begium/Netherlands)

13.20

Why I perform - Foam: Attilio Cavezzi (Italy)

13.40

Why I perform – EV Laser: Nick Morrison (USA)

14.00

Why I perform – Radiofrequency: Ian Franklin (UK)

14.20

Why I perform – Steam: Renè Milleret (France)

14.40

Closing remarks: Martino Neumann (Netherland)

 

 

15.00               Coffee break and visit to Exhibition

                        Chair: Andrew Nicolaides
15.30               Invited Presentation: Norman Rich Vietnam Vascular Registry: Forty-six years on...

15.45-18.30    Joint meeting with Deep Venous Reconstructive Surgery in Chronic Venous
                        Insufficiency Club (DVRS.CVI Club)
                        Chair: Chairman: Robert Kistner
                        Co-Chairman: Seshadri Raju, Michel Perrin

15.45               Overview.  Robert Kistner (USA)
15.55               A strategy of thrombus removal for acute iliofemoral DVT reduces post-thrombotic syndrome. Anthony
                        Comerota (USA)
16.02               Investigation in the perspective of deep venous reconstructive surgery for CVI. 
                        Andrew Nicolaides (Cyprus)
16.09               B-flow during valve repair.  Fedor Lurie (USA)
16.16               CEAP: is it adapted to classify chronic deep venous insufficiency? 
                        Bo Eklof (Sweden)
                        Discussion
16.35               Deep venous reconstructive surgery in primary venous insufficiency.
                        Michel Perrin (France)
16.42               Vein transposition and valve transplant in post-thrombotic syndrome. 
                        Antonio Rosales (Norway)
16.49               The neovalve: techniques and indicates.  Oscar Maleti (Italy)
16.56               The role of endophlebectomy.  Marzia Lugli (Italy)
17.03               Discussion
17.15               Venous stenting in chronic iliac vein obstruction.  Seshadri Raju  (USA)
17.22               IVUS: Should it be used more extensively? Peter Neglen (Cyprus)
17.29               When should stenting be associated with an assisted thrombectomy?
                        Olivier Hartung (France)
17.36               Management of pelvic congestion syndrome.  Javier Leal Monedero (Spain)
17.43               Discussion
17.55               Could deep venous insufficiency be guilty in severe varicose recurrence?
                        Philipe Nicolini (France)
18.02               The rationale of perforator treatment in patients with deep venous insufficiency. 
                        MH Us (Turkey)
18.09               Deep venous surgery: how to assess results: G Danielsson (Sweden)
18.16               Discussion
18.25               Conclusions.  Michel Perrin (France)

18.30               Welcome Reception (Exhibition Hall)

FRIDAY 29 June 2012

08.00-09.05    Didactic Session 2: "Making sense of venous pain: the place of pharmacological treatment"
                        Chairmen:  Andrew Nicolaides, Giovanni Mosti

08.00

Introduction: Giovanni Mosti (Italy)

08.05

Crossing continents—Worldwide results of the VEIN CONSULT Program. Attila Puskas (Romania)

08.25

Why is venous pain so specific? Nicolas Danziger (France)

08.45

Impact of pain on daily life: the role of venoactive drugs such as MPFF. Armando Mansilha (Portugal)

09.00

Conclusion: Andrew Nicolaides

09.05-10.45     Session 1: CCSVI
                        Chair: Paolo Zamboni, Alun Davies

09.05   1.1       A prospective study comparing ultrasonography and angiography for the
                        diagnosis of chronic cerebrospinal venous insufficiency.
                        Simka M, Ludyga T, Kazibudzki M, Latacz P, Janas P.  Euromedic Specialist
                        Clinics, Department of Vascular & Endovascular Surgery, Katowice, Poland

09.25   1.2       The role of duplex ultrasound in chronic cerebrospinal venous insufficiency
                        (CCSVI): A single centre experience with 711 patients.
                        Al-Muzaini A1 , Safar H2 , Sinan T3.  Vascular Imaging Service, Mubarak
                        Al-Kabeer Hospital, Kuwait1, Vascular Surgery Service, Mubarak Al-Kabeer
                        Hospital, Kuwait2, Interventional Vascular Radiology Department, Mubarak
                        Al-Kabeer Hospital, Kuwait. 3 

09.45   1.3       Venous obstructions in the extracranial venous pathway contribute to the
                        disability in multiple sclerosis.
                        1Zorc M, 2Denišlič M, 3Miloševič Z, 1Zorc Pleskovič R, 4Mendiz O, 1Ravnik D.
                        1Medical Faculty, Ljubljana, Slovenia, 2MC Medicor, Ljubljana, Slovenia,
                        3Clinical Centre, Ljubljana, Slovenia, 4Favaloro Foundation, Argentina
                        Submitted in consideration for the EVF Prize

10.05   1.4       Reference values of internal jugular veins haemodynamics on healthy Volunteers.
                        Menegatti E1, Pomidori L2, Paolo C1, Mirko T1, Gianesini S1, Sisini F3, Taibi
                        A3, Malagoni AM1, Cogo A2, Gambaccini M3, Zamboni P11Vascular Diseases Center,
                        University of Ferrara, Ferrara, Italy; 2Biomedical Sport Studies Center, University of Ferrara,
                        Ferrara, Italy,  3Department of Physics,University of Ferrara, Ferrara, Italy
                        Submitted in consideration for the EVF Prize

10.25   1.5       ‘Liberation’ procedure in the treatment of chronic cerebro-spinal venous
                        Insufficiency.  Is chronic cerebro-spinal venous insufficiency related to
                        brain congestive syndrome rather than multiple sclerosis.
                        Milic DJ, Bosnjakovic P, Vojinovic S, Zivic S, Radovanovic Z, Milojkovic V,
                        Ilic A, Stojanov D.  Clinic for Vascular Surgery, Clinical Centre Nis, Serbia

10.45-11.15     Coffee break and visit to Exhibition

11.15-13.30     Session 2: Miscellaneous (10 mins presentation, 7 mins discussion)
                        Chair: Nick Morrison, Marzia Lugli

11.15   2.1       Compression stockings significantly improve haemodynamic performance
                        in post-thrombotic syndrome but their class or length have minimal impact.

                        Lattimer CR, Azzam M, Kalodiki E, Makris GC, Geroulakos G.  Josef Pflug
                        Vascular Unit, Ealing Hospital & Imperial College, London, UK
                        Submitted in consideration for the EVF Prize

11.32   2.2       Interface pressure under non-graduated compression stockings: Practical Consequences.
                        Benigni JP*, Saudez X**.  *HIA Bégin, Saint Mandé, France, **Pierre Fabre
                        Santé, Castres, France

11.49   2.3       To assess the improvement of symptoms for patients CVI with moderate to
                        severe chronic venous disease between new concept of compressive
                        stocking  « Prograssive » and standard compressive stocking degressive (30mmHg).
                        Diamand JM, Vascular Medical Centre, Grenoble, France

12.06   2.4       Clinical and cost efficacy of venous leg ulcer patient treatment – Results of
                        an RCT comparing two compression bandaging systems and standard care
                        without compression
                       Wong IKY1, Andriessen A2, Abel M3.  1 Head of School, School of Nursing,
                        Hong Kong Sanatorium & Hospital, Hong Kong, 2Andriessen Consultants,
                        Malden & UMC St. Radboud, Nijmegen, The Netherlands, 3Head of Medical &
                        Regulatory Affairs, Lohmann& Rauscher, Rengsdorf, Germany.

12.23   2.5       Residual tributaries are the main cause for groin and popliteal surgical
                        recurrence of varicose veins.  A retrospective and prospective study of 610
                        limbs.  Preliminary results of a multicentre study of the Italian Society of
                        Phlebolymphology.
                        Corcos L, Aloi  T, Alonzo U, Amato B, Botta G, Fonti M, Gasbarro  G,
                        Mancini  S, Mattaliano  V, Peruzzi G, Pontello D, Serra R, Spina T, Tondi P,
                        Traina L, Zini F.  Italian Society of Phlebolymphology. Italy.

12.40   2.6       Low thrombotic risk following endovenous laser ablation for chronic venous disease.
                        King T,  McGreevey C, Davis A, Vayuvegula S.  Vein Clinics of America, Downers
                        Grove, Illinolis, USA

12.57   2.7       The disparity in healthcare provision in patients with varicose veins.
                        Moore HM1, Lifsitz A1,2,  Lane T1, Thapar A1, Davies AH1
                        1Academic Section of Vascular Surgery, Department of Surgery & Cancer,
                        Imperial College School of Medicine, Charing Cross Hospital, London, UK.
                        2 Hospital Italiano, Servicio de Cirugia General, Sector Flebolinfologia, Buenos Aires, Argentina
                        Submitted in consideration for the EVF Prize

13.14   2.8       Attitudes towards the management of superficial thrombophlebitis in primary and tertiary care.
                        Sritharan K, Lane TR, Davies AH.  Academic Section of Vascular Surgery,
                        Imperial College, Charing Cross Hospital, London, UK.
                        Submitted in consideration for the EVF Prize

13.30               Lunch

14.30-16.30    Didactic Session 3: “Compression therapy: from imaging to outcomes”
                        Chair: Hugo Partsch, Martino Neumann

14.30

Vein Imaging and Compression.  Jean Francois Uhl (France)

14.50

IPC effects demonstrated by MRI.  Feodor Lurie (USA)

15.10

Report from ICC: challenging dogmas in compression.  Hugo Partsch (Austria)

15.30

New indications for elastic stockings. Giovanni Mosti (Italy)

15.50
16.10

New compression modalities in lymphoedema. Franz Schingale
Compression after vein procedures. Marzia Lugli (Italy)

16.30        Coffee break and visit to Exhibition

17.00               EVF Invited Lecture:
                        Introduction: Giovanni Mosti, President, European Venous Forum
                        Co-chair: Ted King

                        “New insight in venous pathology based on Duplex and biophysics data”.
                        Fedor Lurie (USA)

17.30-18.00     New Oral Anticoagulants
17.30               Phase III Trials.  Andrew Nicolaides (Cyprus)
17.45               Differential effects on thrombogenesis.  Jawed Fareed (USA)
           
18.00-19.10     Session 3: Miscellaneous (10 mins presentation, 7 mins discussion)
                        Chair: Andrew Nicolaides, Alessandro Pieri

18.00   3.1       The incidence of endovenous foam induced thrombosis (EFIT) in 1000 legs
                        in a single vascular centre.
                        Kulkarni SR, Messenger DE, Slim FJA, Emerson LG, Bulbulia RA,
                        Whyman MR, Poskitt KR
                        Cheltenham General Hospital, Cheltenham, UK
                        Submitted in consideration for the EVF Prize

18.17   3.2       Metabolic profile of veins and their implications in primary varicose veins Disease.
                        Anwar MA1, Beckonert OP2, Shalhoub J1, Vorkas PA2, Lim CS1, Want EJ2,
                        Nicholson JK2, Holmes E2, Davies AH1.  1 Academic Section of Vascular
                        Surgery.  2 Section of Biomolecular Medicine, Department of Surgery &
                        Cancer, Imperial College London, UK
                        Submitted in consideration for the EVF Prize

18.34   3.3       Two-year follow-up after ultrasound-guided foam sclerotherapy for
                        varicose veins: Clinical, duplex and health-related quality of life.
                        Darvall KAL, Bate GR, Bradbury AW.  University Department of Vascular
                        Surgery, Birmingham, UK
                        Submitted in consideration for the EVF Prize

18.51               Invited Presentation:
                        Effect of compression on nausea and vomiting in early pregnancy.  Mendoza E.  (Germany)

20.30               Gala Dinner and Presentation of Prizes

 

SATURDAY 30 June 2012

Prize/Awards Session
Chair: Bo Eklof, Pavel Poredoŝ

08.00–08.40    Presentations: American Venous Forum: Servier Award Travelling Fellowship
                        Winners 2012

08.00   P.1      Soluble P-Selectin for the diagnosis of lower extremity deep venous Thrombosis.
                       Vandy FC, Stabler C, Hawley AE, Ballard-Lipka N, Guire KE, Baker N, Myers
                       DD, Rectenwald JE, Henke PK, Wakefield TW.  University of Michigan, Ann Arbor, MI, Department of
                       Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA

08.20   P.2      Reporting the impact of inferior vena cava perforation by filters.
                       Wood EA, Malgor RD, Gasparis AP, Labropoulos N.  Stony Brook University
                       Medical Center, New York, USA

08.40-09.00     Presentation: EVF Pump Priming Grant 2011

08.40   P.3       Characterisation of Biological Factors in the pathogenesis of varicose veins
                        by comprehensive metabolic profiling.
                        Anwar M 1,2, Want E 2, Holmes E 2, Davies A1.  Academic Section of
                        Vascular Surgery1, Section of Biomolecular Medicine2, Department of Surgery
                       & Cancer Imperial College London, UK

09.00-09.20     Winner of the ACP Abstract Award Winner 2011

09.00   P.4       Popliteal Vein Compression.
                        Mauriello J1, White J2, Schroedter W2, Sanchez EJ3
                       1None, Parrish, Florida, USA, 2Quality Vascular Imaging, Venice, Florida,
                       USA, 3Cardiovascular & Vein Center of Florida, Bradenton, Florida, USA

9.20-11.20    Session 4: Miscellaneous
                       Chair: Michel Perrin, Alberto Caggiati

09.20   4.1       Venous disease management in France: Impact of socioeconomic conditions and treatment quality.
                        Guex JJ (1), Allaert FA (2).  1) Phlebologist Nice 2) Chair of Medical
                        Evaluation ESC Dijon,  France

09.40   4.2      A meta-analysis of randomized controlled trials of the main venoactive
                       drugs on the reduction of venous ankle oedema.
                       Allaert FA.   Medical Evaluation Chair ESC Dijon, France

10.00   4.3      Diagnosis and treatment difficulties in the association of the sapheno
                       popliteal valve insufficiency with the insufficiency of the oblique
                       communicating vein of the calf.
                       Ciubotaru V.  Flebestet Medical Clinic, Bucharest, Romania

10.20   4.4      Which artery compresses the left common iliac vein?
                       Caggiati A.  Department of Anatomy, “Sapienza” University of Rome, Italy

10.40   4.5      Closurefast: Obliteration of incompetent varicose veins of large diameter.        Petukhov A2,4,
                       Shaidakov E1,4, Ilyukhin E3, Tsarev O4. 1.  Research Institute of
                        Experimental Medicine  RAMS.  2. “Artmedia”  Clinic.   3. “Medalp” Clinic.
                        4.  Military Medical Academy, Saint Petersburg, Russia


11.00     4.6   Endovenous laser ablation of the great saphenous vein using a bare fibre
                       versus a tulip fibre. A randomized clinical trial.  ISRCTN51287398- The
                       Tulip Trial
                        Vuylsteke ME (1), Thomis S (2), Mahieu P (1), Mordon S (3), Fourneau I (2)
                        (1)Department of Vascular Surgery, Sint-Andriesziekenhuis, Tielt, Belgium.
                        (2)Department of Vascular Surgery, University Hospital Gasthuisberg, Leuven,
                        Belgium.  (3)INSERM U 703, Université Lille Nord de France, Lille University
                        Hospital, Lille, France

11.20-11.50     Coffee break and visit to Exhibition

11.50-12.30     AGM (Members only)

12.30               Lunch

13.30-15.30     Session 5: Miscellaneous
                       Chairmen: Andrew Bradbury, Alessandro Frullini

13.30   5.1      Multicenter evaluation of a novel patient reported outcome tool for
                       assessing efficacy of polidocanol endovenous microfoam (PEM) for
                       treatment of symptomatic visible varicose veins with saphenofemoral
                       junction (SFJ) incompetence: The ProtoSymQ Instrument.

                       Gibson K1, Rush J2, King T2, Evans E2, Wright D2
                       1. Lake Washington Vascular Surgeons, Bellevue, WA, USA
                       2. BTG International Inc., West Conshohocken, PA USA, and London, UK

13.50   5.2      The role of endothelium functional state in truncal vein foam sclerotherapy
                       in patients of different age groups.
                       Shaidakov EV1, Sonkin IN2, Bulatov VL2.  1 - Institute of Experimental Medicine of the Russian Academy
                       of Medical Sciences, St. Petersburg, Russia.
                       2 – Railway Hospital, St. Petersburg, Russia

14.10   5.3      Despite pharmacological equivalence, generic versions of enoxaparin may
                       differ in their pharmacodynamic actions.  Potential clinical implications.

                       Kalodiki E 1,2, Jeske W1, Walenga JM1, Hoppensteadt D1, Mcgeehan E1,
                       Harenberg J3, Fareed J1.  (1) Loyola University Medical Center, Maywood,
                       USA.  (2) Josef Pflug Vascular Unit Ealing Hospital & Imperial College,
                       London, UK.  (3) Ruprecht-Karls University of Heidelberg, Mannhein,
                       Germany

14.30   5.4      In patients with idiopathic venous thrombosis, interleukin-10 is
                       decreased and related to endothelial dysfunction.
                       Ježovnik MK, Poredoš P.   University Medical Centre, Ljubljana, Slovenia

14.50   5.5      In vivo demonstration of sodiumtetradecysulfate sclerosant foam binding
                       with blood proteins.
                       Tessari L*, Cavezzi A**, Izzo M***, Zini F°, M. Tessari°°°, Fanelli R°°
                       * Glauco Bassi Foundation, Trieste, ** Vascular Unit Clinic Stella Maris,
                       S.Benedetto del Tronto,   *** Mat. Tech. Med. Univ. Studi Ferrara, ° Casa di
                       Cura Città di Parma, Parma, °° Mario Negri Pharmacology Institute, Milan, °°°
                       Studi Tessari Peschiera del Garda, Italy.

15.10   5.6      Peri-saphenous tumescence infiltration in long catheter foam sclerotherapy
                       of great sapehnous vein combined with phlebectomy of the varicose
                       tributaries: Any benefit?
                       Cavezzi A *,  Di Paolo S *, Campana F°, Sigismondi G*, Pierantozzi N*,
                       Elio C*, Urso SU*  * Vascular Unit, Clinica Stella Maris and Poliambulatorio
                       Hippocrates, S.Benedetto del Tronto (AP), ° Vascular Medicine Unit, Cesena
                       Hospital, Italy

15.30               Coffee break and visit to exhibition

16.00-17.40     Session 6: Pelvic Vein Disease
                        Chair: Niels Baekgaard, Oscar Maleti

16.00   6.1      Impact of iliac vein compression on subsequent thrombus resolution after deep vein thrombosis.
                       Hosoi Y, Nunokawa M, Takahashi N, Ikezoe T, Kubota H.  Department of
                       Cardiovascular Surgery, Kyorin University, Tokyo, Japan

16.20   6.2       Ultrasound accelerated catheter directed thrombolysis in patients with
                       iliofemoral deep vein thrombosis and in stent thrombosis: Update of
                       clinical experience.
                       Strijkers RHW1, Grommes J2, Arnoldussen CWKP3, Ten Cate-Hoek AJ4,
                        Wittens CHA1,2.  1 Department of Vascular Surgery and Cardiovascular
                        Research Institute Maastricht, Maastricht University, Medical Centre,
                        Maastricht, Limburg, The Netherlands.  2 Department of Vascular Surgery,
                        University Hospital RWTH Aachen, Nordrhein-Westfalen, Germany. 
                        3 Department of Radiology, Maastricht University, Medical Centre, Maastricht,
                        Limburg, The Netherlands.  4 Laboratory for Clinical Thrombosis and
                        Haemostasis and Laboratory of Hematology, Department of Internal Medicine
                        and Cardiovascular Research Institute Maastricht, MUMC+, The Netherlands.

16.40   6.3       Endovascular treatment of pelvic congestion syndrome due to ilio-caval
                        obstructive lesions.
                        Hartung O, Salburgo F, Claudel M, Boufi M, Alimi YS.      
                       Service de Chirurgie Vasculaire, Centre Hospitalier Universitaire Nord, Marseille, France

17.00   6.4       The future of deep vein thrombosis treatment.
                       Arnoldussen CWKPa, Wittens CHAb,c.  a Academisch Ziekenhuis Maastricht,
                       Department of Radiology and Interventional Radiology, Maastricht University
                       Medical Centre, Limburg, The Netherlands.  b Academisch Ziekenhuis
                       Maastricht, Department of Vascular Surgery and Cardiovascular Research
                       Institute Maastricht, Maastricht University Medical Centre, Limburg, The
                       Netherlands.  c Department of Vascular Surgery, University Hospital RWTH
                       Aachen, Nordrhein-Westfalen, Germany

17.20   6.5       Pharmaco-mechanical clot removal in venous occlusions – The use of
                       Angiojet in chronic deep venous thrombosis. 
                       Osse F, Thorpe P.  Centro Endovascular de São Paulo, São Paulo – Brasil

17.40               End of Meeting
                       Presentation of Prizes

 

 

   
top

    Last updated: 09-Dec-2013  
  © Copyright 2006 - European Venous Forum - All rights reserved
Created by: ek